Breaking News Archives

  • Febuary 12, 2007:  Stroke Patients Improve with Movement Therapy: 
    A research study showed that a 2 week program of constraint induced movement therapy (CIMT) improved upper extremity function even after one year in stroke patients with some residual hand and wrist movement. By restraining the good hand with a mitten and requiring use of the affected hand, significant improvements in movement were seen.
    Wolf  SL et al, JAMA. 2006; 296:2095-2104
     
  • February 26, 2007:  Long Term Exposure to Air Pollution Increases Cardiovascular Disease and Death in Women:
    Long term exposure to the fine particulate matter in air pollution increases the incidence of cardiovascular disease and death in postmenopausal women. The increased risk applied to both fatal and nonfatal coronary artery disease and stroke. Each 10µg per cubic meter increase in fine particulate matter caused a 24% increase of a cardiovascular event and a 76% increase in death from cardiovascular disease. Miller KA et al, N Engl J Med 2007; 356:447-58.
     
  • March 5, 2007:  Medical Errors Common in Stroke Care:
    A study of stroke patients admitted to a large teaching hospital showed that medical errors and adverse events occurred frequently. 46% of the injuries were determined to be preventable. Of the preventable injuries, 37% were due to transcription/documentation errors, 23% were due to a failure to perform a clinical task, 10% were due to communication errors, and 10% were due to incorrect calculations. Of the 1,000,000 annual hospital admissions for stroke, 50,000 to 100,000 patients may experience injury caused by medical error. Neurology 2007; 68:550-555, 500-501.
     
  • March 19, 2007: Maternal Diet in Late Pregnancy Affects Children’s Risk for Eczema:
    A recent study showed that a maternal diet high in margarine, vegetable oils and citrus fruits during the last 4 weeks of pregnancy is linked with eczema in children by 2 years of age. The mother’s diet during pregnancy may be a factor that influences the fetal immune responses that cause childhood allergy. The study suggests that mothers eating allergenic foods and foods rich in n-6 polyunsaturated fatty acids (e.g. margarine, vegetable oils, celery and citrus fruit) during pregnancy increase the risk of allergic diseases in their children, while eating foods rich in n-3 polyunsaturated fatty acids such as fish may decrease this risk. Am Jrnl Clin Nutr. 2007; 85:530-537.

  • March 26, 2007: Safety Concerns Persist About Aprotinin:
    Aprotinin (Trasylol) is used during coronary artery bypass grafting (CABG) to reduce bleeding risk. Compared with a lysine analogue (another anti-bleeding agent to reduce bleeding risk) or no antifibrinolytic therapy, aprotinin was associated with an increased mortality risk at 5 years. Pending further FDA evaluation, aprotinin must be used with caution given the availability of lysine analogue as an alternative treatment that was not associated with an increased mortality risk. Mangano DT et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007 Feb 7; 297:4719.

  • April 2, 2007: RotaTeq and Intussusception:
    A Reminder of This Complication: On February 13, 2007, the TDA issued a public health notification that 28 cases of intussusception had been reported after administration of a vaccine against Rotavirus (RotaTeq) since its licensure in February 2006. Intussusception is a form of partial or complete intestinal obstruction usually in children. Cases occurred up to 73 days after administration of the vaccine and half occurred within 21 days. The number of reported intussusceptions is less than the government’s estimated background rate. The FDA is not recommending changes in current vaccination practices, but it wants to encourage reporting of future cases linked to RotaTeq and to remind people of this potential complication of the Rotavirus vaccine. FDA Public Health Notification. Information on RotaTeq and Intussusception
    (Click Here)

  • April 16, 2007: Predicting Early Stroke After TIA:
    Two research groups have developed a unified scoring system to assess patients at high risk for a stroke after experiencing a Transient Ischemic Attach (TIA). Using 7- point scoring tool based on 5 clinical factors (Age, Blood Pressure, Clinical Features, Duration of Symptoms in minutes, and Diabetes), patients can be managed based on the level of risk for early stroke after their TIA. The scoring system identifies patients who require immediate attention, including brain imaging, neurovascular and cardiac evaluation, and hospitalization to allow prompt treatment with clot dissolving medications if a stroke develops. Johnson SC et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007 Jan 27; 369:283-92
     

  • April 30, 2007:     HPV Prevalence in U.S. Women:
    27% of U.S. women test positive for infection with human papillomavirus (HPG). The highest incidence was in women aged 20-24 with a 45% positive rate and declined to 20% in women aged 50 to 59 years of age. The incidence of HPV in women who reported never having sex was 5%. Unfortunately, only 3.4% of HPV types were covered by the new vaccine, which is lower than expected, and this low efficacy rate may change the cost-effectiveness calculation for using the new HPV vaccine. Dunne EF et al.. Prevalence of HPV infection among females in the United Staes. JAMA 2007 Feb 28; 297:813-9.
     

  • May 14, 2007:  Fibrinolysis for Acute Ischemic Stroke: Standard of Care? \
    Despite fibrinolysis being recommended as a first line treatment, many physicians are reluctant to use it because of intracerebral hemorrhage. A recent study using intravenous Alteplase was conducted on ischemic stroke patients aged 18 to 80 who presented within 3 hours of symptoms. The complication of intracerebral hemorrhage occurred in 1.7% and 7.3% of patients at 24 hours and 7 days after therapy respectively. An accurate diagnosis of acute nonhemorrhagic stroke with rapid CT scanning to confirm the absence of bleeding supports the use of a fibrinolytic agent. Though fibrinolysis is not without risk, its benefits in acute stroke are well documented, and emergency room physicians need to work with neurologists and radiologists to establish optimal stroke treatment. WQahlgren N et al. Thrombolysis with alteplase for acute ischemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring (SITS-MOST): An observational study. Lancet 2007 Jan 27; 369:275-82.
     

  • May 28,2007: Outcomes of Myocardial Infarction in Hospitals With Percutaneous Coronary Intervention Facilities:
    Patients with heart attacks who are admitted to hospital that can perform Percutaneous Coronary Intervention (PCI) have better survival than those that go to no-PCI hospitals. PCI includes coronary angiography and treatment with angioplasty and arterial stenting of blocked coronary arteries. Patients admitted to PCI hospitals had lower in-hospital death rates (7% vs. 12%) and lower mortality at one year (13% vs. 20%). Labarere J. et al. Arch Intern Med. 2007;167:913-920.
     

  • June 11, 2007: Prehospital and Hospital Delays After Stroke Onset --- United States, 2005-2006:
    Each year approximately 700,000 persons in the United States have a new or recurrent stroke with 15-30% becoming permanently disabled. The severity of ischemic stroke related disability can be reduced if appropriate treatment is received with intravenous thrombolytic therapy within 3 hours of symptom onset. The study showed that fewer than half of stroke patients arrived at the ER within 2 hours of symptom onset, but that nearly two-thirds of those who arrived at the ER within 2 hours received brain imaging within 1 hour. There is a need for heightened awareness by the public of the importance of recognizing stroke symptoms and to call for an ambulance to get the patient to an ER as quickly as possible. There is also a need for hospitals to streamline procedures for rapid brain imaging of possible ischemic stroke patients. MMMR Weekly. 56(19);474-478 (May 18, 2007).
     

  • July 2, 2007: HPV Vaccine Prevents High Grade Vulval and Vaginal Lesions:
    A study of 18,000 young women showed that, among women without previous exposure to HPV-16 and HPV-18, the quadrilvalent HPV vaccine was 100% effective in preventing high-grade lesions associated with these viryus types. The maximum effect of vaccination is expected in girls who are vaccinated in early adolescence before exposure. HPV-16 and 18 are associated with the development of high-grade vulval and vaginal intraepithelial neoplasia in women. Jura EA et al., Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. The Lancet 2007; 369:1693-1702.

  • July 23, 2007: Studies Find Some Advantage of Back Surgery Over Conservative Treatment:
    Two studies in the New England Journal of Medicine reported that back problems improve more rapidly after surgery than with conservative treatment. In one study of 283 patients, the early surgery group experienced pain relief more quickly, but at one year follow-up there were no differences in the amount of pain, disability or recovery scores. The other study of some 600 patients showed that surgical treatment provided an advantage in both pain relief and functional improvement, and this difference persisted for 2 years after initial injury. In conclusion, it appears that in the absence of major neurological deficits, patients with herniated disks, degenerative spondylolisthesis, or spinal stenosis do not need surgery. However, appropriate surgical procedures may provide earlier and valuable pain relief. Paul WC et al., Surgery versus prolonged conservative treatment for sciatica. N Engl J Med 2007 356;22:2245-56.. Weinstein JN et al. Surgical versus nonsurgical treatment of lumbar degenerative spondylolisthesis. N Engl J Med 2007 356;22:2257-70

  • August 13,2007: Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases:
    A study in the New England Journal of Medicine reported on the efficacy of the quadrivalent HPV vaccine to prevent anogenital disease caused by the virus. Women were followed for vulvar, vaginal, perianal and/or cervical disease for an average of 3 years after the vaccination. Regardless of the HPV, vaccination reduced the rate of any vulvar, vaginal or perianal lesions by 34% and reduced the rate of cervical lesions type by 20%. The quadrivalent vaccine significantly reduced the incidence of HPV-associated anogenital diseases in young women. Garland SM et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital disease, N Engl J Med 2007; 356:1928-43.

  • August 27, 2007: Over The Counter Medications Can be Dangerous:
    The New York City Medical Examiner has determined that the sudden death of an adolescent cross-country runner was caused by the excess use of over-the-counter (OTC) sports creams, such as Ben-Gay and Icy Hot, which she used to relieve sore muscles and joints. The anti-inflammatory agent, salicylic acid, is in the form of oil of wintergreen or batula oil. Exercise and heat, as well as patches, accentuate absorption of the drug into the body. Nausea, vomiting, fatigue, dizziness, convulsions and agitation are symptoms of salicylate poisoning. Extremely high levels of methyl salicylate were found in the teen’s body and caused a fatal seizure. Associated Press. Muscle-pain reliever is blamed for Staten Island runner’s death. New York Times 2007 Jun 10; 1,39.
     

  • September 10, 2007: Middle Age Not Too Late To Lower Cardiac Risk:
    The American Journal of Medicine reports that a healthy lifestyle after age 45 provides cardiovascular benefits and decreases the death rate for individuals at risk of a cardiac event even just after 4 years of life style change. Individuals who ate at least five fruits and vegetables daily, exercised at least 2.5 hours weekly, maintained weight between 18.5 and 30 BMI and stopped smoking had a 40% reduction in all causes of death and a 35% reduction in cardiovascular events, compared with individuals who did not implement all of the studied life style changes. Living a healthy life style is extremely worthwhile and even middle-aged people can benefit from implementing these changes. King DE et al. Turning Back the Clock: Adopting a Healthy Lifestyle in Middle Age. Am. Journ. Medicine. Volume 120:7; 598-603 (2007).
     

  • September 24, 2007: Risk of Blood Clots on Long Planes Rides in 1 in 6000:
    The risk for venous thromboembolism approximately doubles after a plane flight lasting at least 4 hours, but is still only about 1 in 6000, according to the World Health Organization based upon three epidemiological studies and two pathophysiology studies. This risk remains elevated for 2 months after the trip, and the risk of venous thromboembolism is also increased with other forms of travel by car, bus or train, when riders sit immobile for long periods of time. The risk is further increased by obesity, use of oral contraceptives, the presence of factor V Leiden mutation and extremes of height (either above 6’3” or below 5’3”). WHO Research Into Global Hazards of Travel (Wright) Project. June 29, 2007.
     

  • October 8, 2007:  Prostate Cancer Recurrence Declines with Increasing Experience of Surgeon:
    Prostatectomies performed by highly experienced surgeons result in significantly less cancer recurrence than those done by less seasoned doctors, according to a study in the Journal of the National Cancer Institute. There was a steep learning curve that did not begin to plateau until surgeons had done about 250 operations. Recurrence after 5 years was 18% for surgeons who had only done 10 prior operations, compared with 11% fro those surgeons who had done 250 operations. This study provides support for regionalized cancer care, for choosing high-volume surgeons and for basing payments on performance outcomes. Vickers AJ et al, The surgical learning curve for prostate cancer control after radical prostatectomy. JNCI 2007 99(15):1171-1177.

  • October 22, 2007: Hip Protectors Don’t Prevent Fractures Among Nursing Home Residents:
    A study designed to show the efficacy of hip protectors on nursing home patients to prevent hip fractures failed to show any benefit. Hip protectors as currently designed are not effective for preventing hip fractures, and there was no difference in the incidence of hip fractures in residents wearing such protective devices and those who did not. Kiel DP et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents. JAMA. 2007;298:413-422.

  • November 18, 2007: AHA Guidelines for Screening Student Athletes:
    The American Heart Association recently updated its guidelines for screening student athletes. Routine use of 12-lead ECG is not recommended for mass screening, because it is considered impractical and costly, unlike Europe where ECG screening is used. A complete history and physical exam, including specific attention to the cardiovascular system, should be performed. Athlete examinations should be performed every 2 years. Maron BJ et al., Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 Update. Circulation 2007;115:11643-1655.

    December 3, 2007: Cosmetic Eyelash-Lengthener Seized:
    The FDA seized more than 12,000 applicator tubes of Age Intervention Eyelash, a cosmetic designed to increase eyelash growth, because of concerns it may cause eye damage. The product contains bimatoprost (Lumigan) which is used to treat elevated intraocular pressure. Side effects may include optic nerve damage, macular edema and uveitis. No cases of damage have been reported to the manufacturer, but consumers need to be aware of the potential risk. FDA News. Approximately $2 million of potentially harmful “cosmetic” eye product seized. November 16, 2007.

  • TOP

 
   
Telephone 201.444.1644 - 877.963.3625
175 Rock Road, Glen Rock, NJ 07452
Email Britcher,Leone & Roth
© 2006 by: Britcher Leone & Roth, LLC

 
   

Home | About Us | Firm Profiles | Practice Areas | Verdicts & Settlements
News and Events | Legal Articles | FAQ's | Medical & Legal Link
 Contact Us | Case Inquiries
| Site Map